Progressive left lower extremity weakness in a patient with multiple myeloma: A diagnostic dilemma

Extramedullary plasmacytoma is a type of plasma cell dyscrasia that can present as solitary tumor or secondary to multiple myeloma. We experienced a case of intramuscular plasmacytoma in the left thigh muscles of a patient secondary to multiple myeloma. A 73-year-old male with relapsed multiple myeloma and bilateral hip arthroplasty complained of lxeft lower limb weakness and hip pain 3 months after relapse. He underwent contrast-enhanced magnetic resonance imaging of lumbar spine and hip which was inconclusive. Subsequently, patient had multiple admissions for progressive lower limb weakness. His clinical course was complicated by a biopsy-proven plasmacytoma of the neck. He received localized radiation therapy to the neck in addition to a change in multiple myeloma chemotherapy regimen, resulting in resolution of the neck mass but his left lower extremity weakness continued to worsen. Repeat magnetic resonance imaging of hip and spine revealed an intramuscular mass in left thigh which was consistent with the diagnosis of extramedullary plasmacytoma on biopsy. Localized radiation to the thigh accompanied with a change in chemotherapy improved his symptoms and a significant reduction in size of plasmacytoma was observed. When an unexplained lower limb weakness is encountered with a history of multiple myeloma, secondary intramuscular plasmacytoma should be considered.

[1]  Marc-André Weber,et al.  CT and MRI Techniques for Imaging Around Orthopedic Hardware , 2017, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[2]  S. Iida,et al.  t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs , 2015, Blood Cancer Journal.

[3]  I. Ghobrial,et al.  Myeloma as a model for the process of metastasis: implications for therapy. , 2012, Blood.

[4]  J. Bruna,et al.  Key Word and Full-Text Search Member of the Neurologic Complications in Multiple Myeloma and Plasmacytoma , 2018 .

[5]  A. Oriol Multiple myeloma with extramedullary disease , 2011, Advances in therapy.

[6]  J. Bladé,et al.  Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Rozman,et al.  Extensive soft‐tissue involvement by plasmablastic myeloma arising from displaced humeral fractures , 2010, European journal of haematology.

[8]  F. Santiago,et al.  Soft Tissue Extramedullary Plasmacytoma , 2010 .

[9]  C. Pascutto,et al.  Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  R. Spielmann,et al.  Intramuscular manifestation of non-hodgkin lymphoma and myeloma: Prevalence, clinical signs, and computed tomography features , 2010, Acta radiologica.

[11]  G. Morgan,et al.  The impact of extramedullary disease at presentation on the outcome of myeloma , 2009, Leukemia & lymphoma.

[12]  A. Mankodi,et al.  Solitary plasmacytoma presenting as peripheral neuropathy: a case report. , 1999, Neurology India.

[13]  M. Kremer,et al.  Extramedullary plasmacytoma , 1999, Cancer.

[14]  A. Surov,et al.  Intramuscular plasmacytoma , 2014, Skeletal Radiology.